Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain

NCT01905137 is registered in ClinicalTrials.gov with Boston Urogynecology Associates as lead sponsor.

NCT NCT01905137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Lead sponsor
Boston Urogynecology Associates
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
June 30, 2019
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pelvic pain